Clinical Trial to evaluate the efficacy of Siddha Varmam Therapy (SVT) as an addon therapy to Biomedicine among Diabetes patients

Randomized double arm Clinical Trial to evaluate the efficacy of Siddha Varmam Therapy (SVT) among Type II Diabetes Mellitus patients attending Madhumegam Special OPD, SCRU, Tirupati

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/02/031407

Enrollment

Registered

2021-02-19

Start date

Unknown

Completion date

Unknown

Last updated

2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: E11- Type 2 diabetes mellitus

Interventions

Intervention1: Siddha Varmam Therapy alone.: Patient receive Siddha Varmam Therapy alone three days once for the period of 3 months Control Intervention1: Siddha Varmam Therapy and Biomedicine: Patien

Eligibility

Inclusion criteria

Inclusion criteria: 1. Subjects in Age between 30-60 years of both gender 2. Patients having Fasting blood sugar ranging above 100 and below 200 mg/dl 3. HbA1C ranging above 5.5% below 7.5%

Exclusion criteria

Exclusion criteria: 1. Subjects with the age below 30 years and above 60 years are to be excluded from the study. 2. Pregnant women and planning to be pregnant within six months and lactating mother. 3. Known case of i. Malignancy ii. Accelerated Hypertension iii. Coronary artery disease iv. CNS disorders v. Type I Diabetes mellitus vi. Acute infection or fever vii. Chronic viral hepatitis or HIV-infection

Design outcomes

Primary

Measure	Time frame
1.Efficacy of Siddha Varmam therapy on Type II Diabetes Mellitus patients in reducing the FBS, PPBS, HbA1c at baseline, 30, 60, 90 days of treatment.Timepoint: 9 months	—

Secondary

Measure	Time frame
1. Safety of Siddha Varmam therapy on Type II Diabetes Mellitus patients is assessed by comparing Liver function Test and Renal function Test at baseline, 30, 60, 90 days of treatment. 2. Siddha diagnostic tool is validated and tested at baseline, 30, 60, 90 days of treatment. Timepoint: 9 months	—

Countries

India

Contacts

Public ContactDrRajalakshmi

Siddha Clinical Research Unit, Tirupati, Under Central Council for Research in Siddha,

drrajishine@gmail.com09585600845

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026